Materials and Methods Study population. Information of CCM patients admitted between January 2010 and December 2017 to the Department of Neurosurgery of the First Affiliated Hospital of Fujian Medical University was retrospectively reviewed. A total of 167 patients were included, the average age of patients was 39.69 ± 15.27 years, with 43.1% (72/167) being female. The inclusion criteria were: (1) Age >18 years old; (2) diagnosed with CCM based on preoperative imaging, treated with surgery and confirmed with CCM based on postoperative pathological result. Exclusion criteria were: (1) Patient with incomplete disease information, such as missing any of the following: assessment of disease severity (including GCS, KPS and mRS) and WBC differential count (including the WBC count, neutrophil (NEU) count and lymphocyte (LYM) count) at admission, imaging and pathological information, and information on postoperative complications; (2) the patient had any type of surgery or acute or chronic infection within the past month; (3) prior onset of other neurological diseases such as intracranial tumors, stroke or severe head trauma; (4) patient had previous CCM surgery; (5) previous use of immunosuppressants; (6) other systemic diseases, such as autoimmune disease, uremia, cirrhosis, cancer, and chronic lung and heart diseases. The study conformed to the ethical guidelines of the Declaration of Helsinki. The local Ethics Committee of the First Affiliated Hospital of Fujian Medical University (Fujian, China) approved this study and waived the requirement for informed consent because of its retrospective design.